Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: An effect mediated by the HLH factor Id3

Journal of Vascular Research

Volumn 43, Issue 2, 2006, Pages 123-130

  Taylor, Angela M ^a   Li, Feng ^a   Thimmalapura, Pushpa ^a   Gerrity, Ross G ^b   Sarembock, Ian J ^a   Forrest, Scott ^a   Rutherford, Sarah ^a   McNamara, Coleen A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Atherosclerosis; Hypercholesterolemia; Muscle, smooth; Oxidized LDL; Transcription factors

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HELIX LOOP HELIX PROTEIN; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ID 3; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES COMPARISON; SWINE; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HELIX-LOOP-HELIX MOTIFS; HUMANS; HYPERCHOLESTEROLEMIA; INHIBITOR OF DIFFERENTIATION PROTEINS; LIPOPROTEINS, LDL; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; S PHASE; SWINE;

EID: 32644485475     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090131     Document Type: Article

References (35)

1. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Internal Med 2001;161:1413-1419.
2. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
3. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM: The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996;16:831-842.
4. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;89:2462-2478.
5. Lafont A, Libby P: The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol 1998;32:283-285.
6. Lusis AJ: Atherosclerosis. Nature 2000;407:233-241.
7. Braganza DM, Bennett MR: New insights into atherosclerotic plaque rupture. Postgrad Med J 2001;77:94-98.
8. Han CY, Pak YK: Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp Mol Med 1999;31:165-173.
9. Bjorkerud B, Bjorkerud S: Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol 1996;16:416-424.
10. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R: Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J 1995;309:1015-1020.
11. Chatterjee S: Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol Cell Biochem 1992;111:143-147.
12. Chai YC, Howe PH, DiCorleto PE, Chisolm GM: Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem 1996;271:17791-17797.
13. Watanabe T, Pakala R, Katagiri T, Benedict CR: Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation. J Hypertens 2001;19:1065-1073.
14. Kusuhara M, Chait A, Cader A, Berk BC: Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 1997;17:141-148.
15. Zettler ME, Prociuk MA, Austria JA, Massaeli H, Zhong G, Pierce GN: OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol 2003;284:H644-H653.
16. Prabhu S, Ignatova A, Park ST, Sun XH: Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol 1997;17:5888-5896.
17. Peverali FA, Ramqvist T, Saffrich R, Pepperkok R, Barone MV, Philipson L: Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J 1994;13:4291-4301.
18. Olson EN: MyoD family: a paradigm for development? Genes Dev 1990;4:1454-1461.
19. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H: Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991;66:305-315.
20. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995;267:1018-1021.
21. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG: Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998;82:396-403.
22. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG: Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA 1996;93:7905-7910.
23. Matsumura ME, Li F, Berthoux L, Wei B, Lobe DR, Jeon C, Hammarskjold ML, McNamara CA: Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:752-758.
24. Mueller C, Baudler S, Welzel H, Bohm M, Nickenig G: Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin-II-induced cell growth. Circulation 2002;105:2423-2428.
25. Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, Strehlow K, Bohm M: Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J 2002;16:1077-1086.
26. Gerrity RG, Natarajan R, Nadler JL, Kimsey T: Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001;50:1654-1665.
27. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-766.
28. Nordin FG, Hedblad B, Berglund G, Nilsson J: Plasma oxidized LDL: a predictor for acute myocardial infarction? J Int Med 2003;253:425-429.
29. Forrest ST, Barringhaus KG, Perlegas D, Hammarskjold ML, McNamara CA: Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J Biol Chem 2004;279:32897-32903.
30. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995;95:1262-1270.
31. Ohlsson BG, Englund MC, Karlsson AL, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest 1996;98:78-89.
32. Chatterjee S, Bhunia AK, Snowden A, Han H: Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology 1997;7:703-710.
33. Rao GN, Alexander RW, Runge MS: Linoleic acid and its metabolites, hydroperoxyocta-decadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest 1995;96:842-847.
34. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993;91:2572-2579.
35. Yeh K, Lim RW: Genomic organization and promoter analysis of the murine Id3 gene. Gene 2000;254:163-171.